Key result
Coronary CTA detects plaque disruption in ~78% of ACS patients, roughly double the stable rate.
Why the study?
Does coronary computed tomographic angiography (CTA) detect features of plaque disruption in clinically stable patients compared to those with acute coronary syndrome?
Observational (n=145)
Does coronary computed tomographic angiography (CTA) detect features of plaque disruption in clinically stable patients compared to those with acute coronary syndrome?
Coronary CTA can identify 'silent' disrupted plaques in over a third of clinically stable patients, suggesting a potential role in detecting at-risk plaques before acute events.
Answers are grounded in this paper and cite their sources.
CTA-detected plaque disruption in stable patients should not yet change practice; leaves open its prognostic value and need for prospective validation.
AIMS: This study was designed to determine whether coronary CT angiography (CTA) can detect features of plaque disruption in clinically stable patients and to compare lesion prevalence and features between stable patients and those with acute coronary syndrome (ACS). METHODS: We retrospectively identified patients undergoing CTA, followed by invasive coronary angiography (ICA) within 60 days. Quantitative 3-vessel CTA lesion analysis was performed on all plaques ≥25% stenosis to assess total plaque volume, low attenuation plaque (LAP, <50 HU) volume, and remodelling index. Plaques were qualitatively assessed for CTA features of disruption, including ulceration and intra-plaque dye penetration (IDP). ICA was employed as a reference standard for disruption. A total of 145 (94 ACS and 51 stable) patients were identified. By CTA, plaque disruption was evident in 77.7% of ACS cases. Although more common among those with ACS, CTA also detected plaque disruption in 37.3% of clinically stable patients (P < 0.0001). CONCLUSIONS: Clinically stable patients commonly manifest plaques with features of disruption as determined by CTA. Though the prevalence of plaque disruption is less than patients with ACS, these findings support the concept that some clinically stable patients may harbour 'silent' disrupted plaques. These findings may have implications for detection of 'at risk' plaques and patients.
No takes yet. Share an insight, caveat, or question.
Bilolikar et al. (2015) conducted an observational in Stable coronary disease and acute coronary syndrome (n=145). Coronary computed tomographic angiography (CTA) vs. Acute coronary syndrome vs clinically stable patients was evaluated on Detection of plaque disruption by CTA (p=< 0.0001). Coronary CT angiography detected plaque disruption in 37.3% of clinically stable patients compared to 77.7% of patients with acute coronary syndrome (P < 0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: